Reuters logo
BRIEF-Medtronic receives U.S. FDA approval for its HeartWare HVAD System for destination therapy​
September 27, 2017 / 8:11 PM / in 20 days

BRIEF-Medtronic receives U.S. FDA approval for its HeartWare HVAD System for destination therapy​

Sept 27 (Reuters) - Medtronic Plc

* Medtronic HeartWare(TM) HVAD(TM) system approved for destination therapy

* Medtronic Plc - ‍Has received U.S. Food and Drug Administration approval for its HeartWare HVAD System​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below